Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: Correlation with cytologic grading

Diagnostic Cytopathology

Volumn 17, Issue 4, 1997, Pages 267-271

  Sauer, Torill ^a   Beraki, Kahsai ^a   Jebsen, Peter Wilhelm ^a   Ormerod, Eli ^a   Naess, Oddvar ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytologic grading; DNA; Fine needle aspirates; In situ hybridization; Ploidy

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER GRADING; CELL NUCLEUS; CHROMOSOME 13; CHROMOSOME 17; CYTOLOGY; DISOMY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL NUCLEUS; CYTODIAGNOSIS; DNA, NEOPLASM; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INTERPHASE; PLOIDIES;

EID: 0030841575     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199710)17:4<267::AID-DC6>3.0.CO;2-9     Document Type: Article

References (33)

1. Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma, Anal Quanl Cytol 1980;2:161-165.
2. Meyer JS, McDivitt RW, Stone KR. Practical breast carcinoma kinetics: review and update. Breast Cancer Res Treat 1984;4:79-88.
3. Berryman IL, Harvey JM, Sterrett GF, Papadimitriou JM. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome. Anal Quant Cytol Histol 1987;9:429-434.
4. Chen L, Kurisu W, Ljung B-M, Goldman ES, Moore D II, Smith HS. Heterogeneity for allelic loss in human breast cancer. JNCI 1992;84:506-310.
5. Herrington CS, Leek RD, McGec JO'D. Correlalion of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes, J Pathol 1995;176:353-359.
6. Devilee P, van Vliet M. van Sloun P. et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogens 1991;6:1705-1711.
7. Chen LC, Neubauer A, Kurisi W, et al. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferate capacity and DNA aneuploidy in primary breast cancer. Proc Natl Acad Sci USA 1991;88:3847-3851.
8. Bieche I, Champeme MH, Malifas F, Hacene K, Callahan R, Lidereau R. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 1992;339:139-143.
9. Watatani M, Nagayama K, Imanishi Y, et al. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Res Treat 1993;28:231-239.
10. Farabegoli F, Baldini N, Santini D, et al. Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study. J Clin Pathol 1996;49:98-103.
11. Thompson AM, Steel CM, Chetty U, et al. P53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer 1990;61:74-78.
12. Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR. Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologic specimens. Diagn Cytpathol 1995;13:486-492.
13. Cajulis RS, Frias-Hidvegi D, Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Acta Cytol 1993;37:391-396.
14. Bloom HJG, Richardson WW, Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377.
15. Fisher ER, Redmond C, Fisher B, Histologic grading of breast cancer. Pathol Annu 1980;15:239-251.
16. O'Reilly SM, Camplejohn RS, Millis RR, Allen D, Rubens RD, Richards MA. DNA index. S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990;61:671-674.
17. Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer-A study with long-term follow-up. Br J Cancer 1989;60:693-700.
18. Cajulis RS, Sneige N, El-Naggar A. Cytologic nuclear grading of fine needle aspirates of breast carcinoma: concordance with corresponding histologic grading and How cytometric data. Mod Pathol 1990;3:14A.
19. Hunt CM, Ellis IO, Elston CW, Locker A, Pearson D, Blarney RW. Cytological grading of breast carcinoma-A feasible proposition? Cytopathology 1990;1:287-295.
20. Ciatto S. Bonardi R. Herd-Smith A, Cariaggi P, Confortini M, Bulgaresi P. Prognostic value of breast cancer cytologic grading: a retrospective study of 213 cases. Diagn Cytopathol 1993;9:160-163.
21. Dabbs D. Role of nuclear grading of breast carcinomas in fine needle aspiration specimens. Acta Cytol 1993;37:361-366.
22. Cajulis RS, Hessel RG, Hwang S, Haines K, Frias-Hidvegi D, O'Gorman M. Simplified nuclear grading of fine-needle aspirates of breast carcinoma: concordance with corresponding histologic nuclear grading and How cytometric data. Diagn Cytopathol 1993;11:124-130.
23. Robinson IA, MeKee G, Nicholsen A, et al. Prognostic value of cytologic grading of fine-needle aspirates from breast carcinomas. Lancet 1994;343:947-949.
24. Ichikawa D, Hashimoto N, Hoshima M, et al. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 1996;77:2064-2069.
25. Cajulis RS, Kotliar S, Haines GK, Frias-Hidvegi D, O'Gorman M. Comparative study of interphase cytogenetics. flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn Cytpathol 1994;11:151-158.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
27. Fallenius AG, Auer GU, Carstensen JM. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 1988;62:331-341.
28. Leong AS-Y, Lee AKC. Biological indices in the assessment of breast cancer. J Clin Pathol 1995;48:221-238.
29. Baeus SS, Baeus JW, Slamon DJ, Press MF. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer. Arch Pathol Lab Med 1990;114:164-169.
30. Visscher DW, Sarkar FH, Crissman JD. Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. Anal Quant Cytol Histol 1991;13:418-424.
31. Lee AK, Wiley B, Loda M, et al. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma. Mod Pathol 1992;5:61-67.
32. Troneone G, Zeppa P, Fuleiniti F, et al. C-erbB-2 expression and DNA ploidy status in breast cancer cells obtained by fine needle aspiration tFNAI. Cytopathology 1993;4:195-205.
33. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB Nm23 protein expression in ductal in situ and invasive human breast carcinoma. JNCI 1993;85:727-731.